TIMP2 and rheumatoid arthritis: This difference was due in part to the high prevalence of TIMP-2 antibodies in the samples of patients with nonerosive RA (44% versus 22%, P = 0.024), while the incidence of antibodies to other TIMPs was similar in erosive and nonerosive RA.